These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 10624422)

  • 1. The correlation between cell surface markers and clinical features in choroidal malignant melanomas.
    Lawry J; Currie Z; Smith MO; Rennie IG
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():301-8. PubMed ID: 10624422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous cell cycle and phenotypic analysis of primary uveal melanoma by flow cytometry.
    Lawry J; Smith MO; Parsons MA; Rennie IG
    Eye (Lond); 1998; 12 ( Pt 3a)():431-9. PubMed ID: 9775246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of DNA content in uveal melanomas by flow cytometry.
    Rennie IG; Rees RC; Parsons MA; Lawry J; Cottam D
    Eye (Lond); 1989; 3 ( Pt 5)():611-7. PubMed ID: 2630338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
    Richardson RP; Lawry L; Rees RC; Rennie IG
    Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The importance of flow cytometry and the cell proliferation index in choroidal melanoma].
    Ranty ML; Quintyn JC; Courville P; Brasseur G
    J Fr Ophtalmol; 2003 Sep; 26(7):725-9. PubMed ID: 13130261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA flow cytometry of malignant melanoma of the choroid].
    Fuchs M; Wohlrab W; Klapperstück T; Fuchs U
    Ophthalmologe; 1993 Oct; 90(5):496-500. PubMed ID: 8219639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognostic significance of HSP-70, c-myc and HLA-DR expression in patients with malignant melanoma.
    Ricaniadis N; Kataki A; Agnantis N; Androulakis G; Karakousis CP
    Eur J Surg Oncol; 2001 Feb; 27(1):88-93. PubMed ID: 11237497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA expression in choroidal melanomas: correlation with clinicopathological features.
    Krishnakumar S; Abhyankar D; Lakshmi SA; Pushparaj V; Shanmugam MP; Biswas J
    Curr Eye Res; 2004 Jun; 28(6):409-16. PubMed ID: 15512948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.
    Béliveau A; Bérubé M; Rousseau A; Pelletier G; Guérin SL
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2363-72. PubMed ID: 10892885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term follow-up of c-myc, p53 and proliferation measurements in malignant melanoma.
    Ross DA; Laing JH; Sanders R; Wilson GD
    Eur J Surg Oncol; 2006 Feb; 32(1):80-4. PubMed ID: 16256294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor markers in malignant choroid melanoma].
    Scheiffarth OF; Strobl J; Stefani FH; Riedel KG; Scheidhauer K
    Fortschr Ophthalmol; 1989; 86(6):639-43. PubMed ID: 2696716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions.
    Natali P; Nicotra MR; Cavaliere R; Bigotti A; Romano G; Temponi M; Ferrone S
    Cancer Res; 1990 Feb; 50(4):1271-8. PubMed ID: 1967552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric DNA analysis of primary cutaneous malignant melanoma.
    Ohnishi K; Ishikawa H
    Acta Derm Venereol; 1991; 71(6):525-8. PubMed ID: 1685836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and distribution of MMPs and TIMPs in human uveal melanoma.
    Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC
    Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.